PRA Health Sciences’ Early Development Services (EDS) group has a long-standing record of early clinical development work in various neuroscience and pain indication. In the past decade, PRA EDS in the Netherlands has gained extensive experience in neuroactive drug development through 160+ Phase I and Phase II clinical studies. PRA’s US clinical research centers offer addition expertise in neuroscience and pain early phase trials.

Explore related content and topics